Time Trends (2012–2020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain

Abstract

(1) Background: To analyze time trends, sex differences, and factors associated with influenza vaccination uptake among individuals with COPD in Spain, 2012–2020. (2) Methods: A cross-sectional study based on data from the European Health Surveys for Spain, 2020 (EHSS2020) and 2014 and from the Spanish National Health Interview Surveys for 2017 and 2012. (3) Results: The study included 65,447 participants. Prevalence of COPD was 5.9% (n = 3855). Overall, the influenza vaccination uptake among COPD patients was 57.8% versus 28.6% for those without COPD (p < 0.001). Men with COPD reported higher uptake than women in all the surveys studied. Neither the crude nor the multivariable analysis showed a significant variation change overtime for people with COPD. However, among those aged <65 years, crude uptake decreased from 2012 to 2020 (39.4% vs. 33.3%; p = 0.039). Over the entire period, men were vaccinated significantly more than women (OR 1.28; 95% CI 1.12–1.47). Among COPD participants, included in the EHSS2020, independent predictors of vaccine uptake included being male, higher age, reporting no current smoking and suffering cancer or heart disease. (4) Conclusions: In COPD patients, the influenza vaccination uptake is below desirable levels and did not improve from 2012 to 2020. Sex differences are found, with consistent and constant lower uptake among women with COPD. The observed lower uptake among COPD women and patients with unhealthy lifestyle requires increased attention.

Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data

“…[ 23 , 28 , 35 ] Current smokers had lower vaccination uptake, confirming the results of previous studies which have shown that among patients with COPD, those with unhealthy lifestyles are less likely to be vaccinated. [ 23 , 24 , 36 ] Contrary to the findings of previous studies, [ 29 , 37 ] this study showed that vaccination coverage was inversely associated with severe exacerbation history in the past year, suggesting these patients with frequent exacerbations should be a target population in which vaccination coverage need to increase. In addition, this study found that patients with low vaccination coverage had poor adherence to pharmacological and non-pharmacological therapies.…”

First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary

“…The reduction in the number of potentially fatal exacerbations also justifies effective preventive measures, including vaccination, to reduce the risk of COVID-19 infection in COPD patients and current smokers. There are gender differences in vaccine uptake in COPD patients, e.g., lower uptake of influenza vaccine among women (32) and lower uptake of COVID-19 vaccine, than men (33). This is confirmed by our present study.…”

Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic

“…Thus, in the 2014–2015 season, differences in vaccination coverage by sex of up to 13.4 percentage points were documented in Spain among men aged 80 and over compared to women in that age group [ 33 ]. Similar differences have been documented in other types of patients [ 34 , 35 , 36 ], such as splenectomized patients (with flu vaccination coverage rates of 63.3% in men and 50% in women) [ 34 ] or individuals with chronic obstructive pulmonary disease (with vaccination rates of 62.6% in men and 53.6% in women in the 2012–2013 campaign) [ 36 ]. A contributing factor to this unexpected finding is perhaps the pandemic of the new SARS-CoV-2, in which influenza vaccination to avoid possible coinfection with the two viruses may have been a particularly important reason for women to be vaccinated.…”